CRISTINA RELIHAN: Open Payments
NPI 1518340140 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,570 in 77 payments from 27 companies in 2025. Trend: 2023 $1,611 · 2024 $2,173 · 2025 $1,570
Food & beverage: $1,570
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $316 |
| ABBVIE INC. | 10 | $169 |
| PFIZER INC. | 7 | $152 |
| AstraZeneca Pharmaceuticals LP | 6 | $105 |
| Lilly USA, LLC | 5 | $103 |
| Dexcom, Inc. | 2 | $78 |
| Exact Sciences Corporation | 3 | $70 |
| Amgen Inc. | 4 | $65 |
| Inspire Medical Systems, Inc. | 2 | $55 |
| GENZYME CORPORATION | 2 | $49 |
Products named: Ozempic, Dexcom G6 Transmitter, MOUNJARO, NURTEC ODT, Cologuard Collection Kit, OTEZLA, LINZESS, BREZTRI.
Industry payments across FL — which companies pay providers there.
